Top compounds associated with response to TM9SF3


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
mRNA AZD4547 CTRPv2 pan-cancer AAC 0.049 0.2
mRNA WH-4-023 GDSC1000 pan-cancer AAC 0.061 0.2
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.044 0.2
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
mRNA Epothilone B FIMM pan-cancer AAC -0.2 0.2
mRNA linifanib GDSC1000 pan-cancer AAC 0.042 0.2
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.042 0.2
mRNA OSI-027 CTRPv2 pan-cancer AAC -0.044 0.2
mRNA isoevodiamine CTRPv2 pan-cancer AAC -0.041 0.2
Download CSV